Stephen Snowdy

Alveolus, Inc. used to develop non-vascular interventional stent technology. The company was founded by Eric K. Mangiardi and Gerard A. Silvestri in 2001 and is headquartered in Charlotte, NC.

Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO.

Protein Discovery, Inc. is a privately held life sciences company that develops, markets and sells innovative sample preparation products for the measurement of proteins. Their products help academic, biotechnology and pharmaceutical scientists advance their protein research and biotherapeutic development by enabling more sensitive, more accurate, and faster analyses. Protein Discovery is focused on developing and commercializing innovative sample preparation technologies that enable more sensitive, more accurate, and faster protein and peptide analysis using mass spectrometry. PPS Silent Surfactant is a patented detergent that replaces conventional protein extraction and solubilization detergents that either interfere with mass spectrometry or cause other problems in use at the lab bench. The Gelfree 8100 Fractionation System is a patent-pending system that provides molecular weight-based fractionation of intact proteins with liquid phase recovery. And the Passport 1200 Sample Prep System provides enrichment of low molecular weight proteins and peptides for high-throughput quantification applications. Protein Discovery’s innovative sample preparation solutions unlock the power of mass spectrometry for protein and peptide analysis. The company was founded by Charles E. Witkowski II in 2001 and is headquartered in Knoxville, Tennessee.

KFx Medical LLC engages in manufacturing soft tissue fixation implants for orthopedic sports medicine surgeons. The company was founded by Ronald R. Giannotti and Alec Piplani in 2003 and is headquartered in Solana Beach, CA.

Calosyn Pharma, Inc. develops intra-articular therapeutics for osteoarthritis. Its product is based on a class of drugs known as calcium channel blockers. The firm's drugs is used in humans for the treatment of heart and vascular diseases. The company was founded by David D. Waddell and is headquartered in Atlanta, GA.